Mr. Ilan Sobel reports

BIOHARVEST SCIENCES TO HOST CORPORATE UPDATE CALL MAY 2 AT 2:30 P.M. EASTERN TIME

Bioharvest Sciences Inc. will host a corporate update call on Thursday, May 2, 2024, to discuss recently announced milestone achievements, including full-year 2023 financial results and the recent acquisition of an expanded corporate campus.

Chief executive officer Ilan Sobel and chairman Zaki Rakib will host the call at 2:30 p.m. Eastern Time on Thursday, May 2, 2024, with a formal presentation providing their comments on the 2023 financial results, on the recent acquisition of a new corporate campus and on the proposed path for the company to meet Nasdaq listing requirements. The shareholder update call will feature a live question-and-answer session. To participate, please use the following information.

Fourth quarter 2023 shareholder update webinar

Date:  Thursday, May 2, 2024

Time:  2:30 p.m. Eastern Time

Please join at least five minutes before the start of the call to ensure timely participation.

Mr. Rakib said: "We have achieved multiple milestones over the last several months, building on our strong pace of operational execution. In preparation for future growth, we recently announced that we secured an 80,000-square-foot facility in Israel with a 50-tonne manufacturing capacity and additional space to consolidate our laboratory and office facilities under a single roof. This included 12 state-of-the-art clean rooms, which will prove instrumental as we scale our CDMO [contract development and production organization] services business in the quarters to come."

Mr. Sobel added: "We announced yesterday our fourth quarter financial results, highlighted by an 85-per-cent increase in revenue to a record $4.5-million. We continued to strengthen our margins as well, growing them to 51 per cent in the fourth quarter, as compared with 27 per cent in the prior year. This financial performance, when paired with the pipeline of incremental growth drivers in our D2C [direct-to-consumer] products and CDMO services business units, positions us well in 2024 to drive continued financial momentum across our business."

About Bioharvest Sciences Inc.

Bioharvest Sciences is a leader in botanical synthesis, leveraging its patented technology platform to grow plant-based molecules, without the need to grow the underlying plant. Bioharvest is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two major business verticals; as a contract development and production organization (CDMO) on behalf of customers seeking complex molecules; and as a creator of proprietary nutraceutical health and wellness products, which include dietary supplements.

We seek Safe Harbor.